Copyright Reports & Markets. All rights reserved.

Global Hybrid Brain–Computer Interface (hBCI) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Hybrid Brain–Computer Interface (hBCI) Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Invasive
    • 1.3.3 Non-invasive
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Hybrid Brain–Computer Interface (hBCI) Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Healthcare
    • 1.4.3 Entertainment and Education
    • 1.4.4 Others
  • 1.5 Global Hybrid Brain–Computer Interface (hBCI) Market Size & Forecast
    • 1.5.1 Global Hybrid Brain–Computer Interface (hBCI) Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Hybrid Brain–Computer Interface (hBCI) Sales Quantity (2021-2032)
    • 1.5.3 Global Hybrid Brain–Computer Interface (hBCI) Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Neuralink
    • 2.1.1 Neuralink Details
    • 2.1.2 Neuralink Major Business
    • 2.1.3 Neuralink Hybrid Brain–Computer Interface (hBCI) Product and Services
    • 2.1.4 Neuralink Hybrid Brain–Computer Interface (hBCI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Neuralink Recent Developments/Updates
  • 2.2 NeuroSky
    • 2.2.1 NeuroSky Details
    • 2.2.2 NeuroSky Major Business
    • 2.2.3 NeuroSky Hybrid Brain–Computer Interface (hBCI) Product and Services
    • 2.2.4 NeuroSky Hybrid Brain–Computer Interface (hBCI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 NeuroSky Recent Developments/Updates
  • 2.3 NeuroPace
    • 2.3.1 NeuroPace Details
    • 2.3.2 NeuroPace Major Business
    • 2.3.3 NeuroPace Hybrid Brain–Computer Interface (hBCI) Product and Services
    • 2.3.4 NeuroPace Hybrid Brain–Computer Interface (hBCI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 NeuroPace Recent Developments/Updates
  • 2.4 EMOTIV
    • 2.4.1 EMOTIV Details
    • 2.4.2 EMOTIV Major Business
    • 2.4.3 EMOTIV Hybrid Brain–Computer Interface (hBCI) Product and Services
    • 2.4.4 EMOTIV Hybrid Brain–Computer Interface (hBCI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 EMOTIV Recent Developments/Updates
  • 2.5 Blackrock Neurotech
    • 2.5.1 Blackrock Neurotech Details
    • 2.5.2 Blackrock Neurotech Major Business
    • 2.5.3 Blackrock Neurotech Hybrid Brain–Computer Interface (hBCI) Product and Services
    • 2.5.4 Blackrock Neurotech Hybrid Brain–Computer Interface (hBCI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Blackrock Neurotech Recent Developments/Updates
  • 2.6 Compumedics
    • 2.6.1 Compumedics Details
    • 2.6.2 Compumedics Major Business
    • 2.6.3 Compumedics Hybrid Brain–Computer Interface (hBCI) Product and Services
    • 2.6.4 Compumedics Hybrid Brain–Computer Interface (hBCI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Compumedics Recent Developments/Updates
  • 2.7 Advanced Brain Monitoring
    • 2.7.1 Advanced Brain Monitoring Details
    • 2.7.2 Advanced Brain Monitoring Major Business
    • 2.7.3 Advanced Brain Monitoring Hybrid Brain–Computer Interface (hBCI) Product and Services
    • 2.7.4 Advanced Brain Monitoring Hybrid Brain–Computer Interface (hBCI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Advanced Brain Monitoring Recent Developments/Updates
  • 2.8 G.TEC
    • 2.8.1 G.TEC Details
    • 2.8.2 G.TEC Major Business
    • 2.8.3 G.TEC Hybrid Brain–Computer Interface (hBCI) Product and Services
    • 2.8.4 G.TEC Hybrid Brain–Computer Interface (hBCI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 G.TEC Recent Developments/Updates
  • 2.9 Neuroelectrics
    • 2.9.1 Neuroelectrics Details
    • 2.9.2 Neuroelectrics Major Business
    • 2.9.3 Neuroelectrics Hybrid Brain–Computer Interface (hBCI) Product and Services
    • 2.9.4 Neuroelectrics Hybrid Brain–Computer Interface (hBCI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Neuroelectrics Recent Developments/Updates
  • 2.10 Brain Products
    • 2.10.1 Brain Products Details
    • 2.10.2 Brain Products Major Business
    • 2.10.3 Brain Products Hybrid Brain–Computer Interface (hBCI) Product and Services
    • 2.10.4 Brain Products Hybrid Brain–Computer Interface (hBCI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Brain Products Recent Developments/Updates
  • 2.11 ANT Neuro
    • 2.11.1 ANT Neuro Details
    • 2.11.2 ANT Neuro Major Business
    • 2.11.3 ANT Neuro Hybrid Brain–Computer Interface (hBCI) Product and Services
    • 2.11.4 ANT Neuro Hybrid Brain–Computer Interface (hBCI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 ANT Neuro Recent Developments/Updates
  • 2.12 BrainCo
    • 2.12.1 BrainCo Details
    • 2.12.2 BrainCo Major Business
    • 2.12.3 BrainCo Hybrid Brain–Computer Interface (hBCI) Product and Services
    • 2.12.4 BrainCo Hybrid Brain–Computer Interface (hBCI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 BrainCo Recent Developments/Updates
  • 2.13 Neuracle
    • 2.13.1 Neuracle Details
    • 2.13.2 Neuracle Major Business
    • 2.13.3 Neuracle Hybrid Brain–Computer Interface (hBCI) Product and Services
    • 2.13.4 Neuracle Hybrid Brain–Computer Interface (hBCI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Neuracle Recent Developments/Updates
  • 2.14 Flexolink
    • 2.14.1 Flexolink Details
    • 2.14.2 Flexolink Major Business
    • 2.14.3 Flexolink Hybrid Brain–Computer Interface (hBCI) Product and Services
    • 2.14.4 Flexolink Hybrid Brain–Computer Interface (hBCI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Flexolink Recent Developments/Updates
  • 2.15 NeuralFlex
    • 2.15.1 NeuralFlex Details
    • 2.15.2 NeuralFlex Major Business
    • 2.15.3 NeuralFlex Hybrid Brain–Computer Interface (hBCI) Product and Services
    • 2.15.4 NeuralFlex Hybrid Brain–Computer Interface (hBCI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 NeuralFlex Recent Developments/Updates

3 Competitive Environment: Hybrid Brain–Computer Interface (hBCI) by Manufacturer

  • 3.1 Global Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Hybrid Brain–Computer Interface (hBCI) Revenue by Manufacturer (2021-2026)
  • 3.3 Global Hybrid Brain–Computer Interface (hBCI) Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Hybrid Brain–Computer Interface (hBCI) by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Hybrid Brain–Computer Interface (hBCI) Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Hybrid Brain–Computer Interface (hBCI) Manufacturer Market Share in 2025
  • 3.5 Hybrid Brain–Computer Interface (hBCI) Market: Overall Company Footprint Analysis
    • 3.5.1 Hybrid Brain–Computer Interface (hBCI) Market: Region Footprint
    • 3.5.2 Hybrid Brain–Computer Interface (hBCI) Market: Company Product Type Footprint
    • 3.5.3 Hybrid Brain–Computer Interface (hBCI) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hybrid Brain–Computer Interface (hBCI) Market Size by Region
    • 4.1.1 Global Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Hybrid Brain–Computer Interface (hBCI) Consumption Value by Region (2021-2032)
    • 4.1.3 Global Hybrid Brain–Computer Interface (hBCI) Average Price by Region (2021-2032)
  • 4.2 North America Hybrid Brain–Computer Interface (hBCI) Consumption Value (2021-2032)
  • 4.3 Europe Hybrid Brain–Computer Interface (hBCI) Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Hybrid Brain–Computer Interface (hBCI) Consumption Value (2021-2032)
  • 4.5 South America Hybrid Brain–Computer Interface (hBCI) Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Type (2021-2032)
  • 5.2 Global Hybrid Brain–Computer Interface (hBCI) Consumption Value by Type (2021-2032)
  • 5.3 Global Hybrid Brain–Computer Interface (hBCI) Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Application (2021-2032)
  • 6.2 Global Hybrid Brain–Computer Interface (hBCI) Consumption Value by Application (2021-2032)
  • 6.3 Global Hybrid Brain–Computer Interface (hBCI) Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Type (2021-2032)
  • 7.2 North America Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Application (2021-2032)
  • 7.3 North America Hybrid Brain–Computer Interface (hBCI) Market Size by Country
    • 7.3.1 North America Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Hybrid Brain–Computer Interface (hBCI) Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Type (2021-2032)
  • 8.2 Europe Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Application (2021-2032)
  • 8.3 Europe Hybrid Brain–Computer Interface (hBCI) Market Size by Country
    • 8.3.1 Europe Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Hybrid Brain–Computer Interface (hBCI) Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Hybrid Brain–Computer Interface (hBCI) Market Size by Region
    • 9.3.1 Asia-Pacific Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Hybrid Brain–Computer Interface (hBCI) Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Type (2021-2032)
  • 10.2 South America Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Application (2021-2032)
  • 10.3 South America Hybrid Brain–Computer Interface (hBCI) Market Size by Country
    • 10.3.1 South America Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Hybrid Brain–Computer Interface (hBCI) Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Market Size by Country
    • 11.3.1 Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Hybrid Brain–Computer Interface (hBCI) Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Hybrid Brain–Computer Interface (hBCI) Market Drivers
  • 12.2 Hybrid Brain–Computer Interface (hBCI) Market Restraints
  • 12.3 Hybrid Brain–Computer Interface (hBCI) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hybrid Brain–Computer Interface (hBCI) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hybrid Brain–Computer Interface (hBCI)
  • 13.3 Hybrid Brain–Computer Interface (hBCI) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hybrid Brain–Computer Interface (hBCI) Typical Distributors
  • 14.3 Hybrid Brain–Computer Interface (hBCI) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Hybrid Brain–Computer Interface (hBCI) market size was valued at US$ 498 million in 2025 and is forecast to a readjusted size of US$ 702 million by 2032 with a CAGR of 5.1% during review period.
    A typical hybrid BCI is also composed of one BCI and another system (which might be another BCI), and must also achieve specific goals better than a conventional system. For example, a hybrid BCI might infer user intent more accurately during imagery-based and/or visual attention-based experimental paradigms, improve the overall performance of the system, or reduce the rate of false positives during resting periods of i.e. steady-state visual evoked potential (SSVEP)-based BCI applications.
    This report is a detailed and comprehensive analysis for global Hybrid Brain–Computer Interface (hBCI) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Hybrid Brain–Computer Interface (hBCI) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Hybrid Brain–Computer Interface (hBCI) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Hybrid Brain–Computer Interface (hBCI) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Hybrid Brain–Computer Interface (hBCI) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Hybrid Brain–Computer Interface (hBCI)
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Hybrid Brain–Computer Interface (hBCI) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Neuralink, NeuroSky, NeuroPace, EMOTIV, Blackrock Neurotech, Compumedics, Advanced Brain Monitoring, G.TEC, Neuroelectrics, Brain Products, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Hybrid Brain–Computer Interface (hBCI) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Invasive
    Non-invasive
    Market segment by Application
    Healthcare
    Entertainment and Education
    Others
    Major players covered
    Neuralink
    NeuroSky
    NeuroPace
    EMOTIV
    Blackrock Neurotech
    Compumedics
    Advanced Brain Monitoring
    G.TEC
    Neuroelectrics
    Brain Products
    ANT Neuro
    BrainCo
    Neuracle
    Flexolink
    NeuralFlex
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Hybrid Brain–Computer Interface (hBCI) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Hybrid Brain–Computer Interface (hBCI), with price, sales quantity, revenue, and global market share of Hybrid Brain–Computer Interface (hBCI) from 2021 to 2026.
    Chapter 3, the Hybrid Brain–Computer Interface (hBCI) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Hybrid Brain–Computer Interface (hBCI) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Hybrid Brain–Computer Interface (hBCI) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Hybrid Brain–Computer Interface (hBCI).
    Chapter 14 and 15, to describe Hybrid Brain–Computer Interface (hBCI) sales channel, distributors, customers, research findings and conclusion.

    Buy now